Use of mesna prophylaxis in patients with cyclophosphamide-treated ANCA-associated vasculitis: cross-sectional survey of practitioners.

Publikation

Use of mesna prophylaxis in patients with cyclophosphamide-treated ANCA-associated vasculitis: cross-sectional survey of practitioners.

Wissenschaftlicher Artikel/Review - 27.06.2024

Joos Lukas, Gonzalez Chiappe Solange, Neumann Thomas, Mahr Alfred

Zitation

Joos L, Gonzalez Chiappe S, Neumann T, Mahr A. Use of mesna prophylaxis in patients with cyclophosphamide-treated ANCA-associated vasculitis: cross-sectional survey of practitioners. Rheumatol Int 2024; 44:3099-3106.

Art

Wissenschaftlicher Artikel/Review (Englisch)

Zeitschrift

Rheumatol Int 2024; 44

Veröffentlichungsdatum

27.06.2024

eISSN (Online)

1437-160X

Seiten

3099-3106

Kurzbeschreibung/Zielsetzung

There may be some diversity in the practice of co-prescribing 2-mercaptoethane sodium sulfonate (mesna) with cyclophosphamide (CYC) for ANCA-associated vasculitis (AAV).